Good answer Hilton.
Since you are a clinician scientist, what is your read on the efficacy of the drug, now that we know that 27 median months have passed (so 50% longer trail) with 10% more MACE (275 vs 250)? Does it pass muster for you? Or is the unknowns (like MACE rate for placebo) too much for you to come ANY conclusion?